Proteome Sciences (LON:PRM) Announces Earnings Results

Proteome Sciences (LON:PRM) released its quarterly earnings results on Wednesday. The company reported GBX (0.41) earnings per share for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

Proteome Sciences Stock Performance

PRM opened at GBX 1.38 on Wednesday. The company has a debt-to-equity ratio of -165.46, a current ratio of 0.13 and a quick ratio of 0.37. The business has a fifty day simple moving average of GBX 1.72 and a 200 day simple moving average of GBX 1.64. Proteome Sciences has a 1 year low of GBX 1.11 and a 1 year high of GBX 4.40. The company has a market capitalization of £4.82 million, a PE ratio of -1.32 and a beta of 0.16.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.